(Q30162)
Statements
Research in gender-affirming chest surgery has primarily compared cisgender versus transgender and gender-diverse (TGD) people, without specifically addressing nonbinary people. (English)
INTRODUCTION (English)
Copyright © 2024. Published by Elsevier Inc. (English)
2024
This study will assess surgical complications between cisgender, transgender, and nonbinary adults undergoing breast reductions. (English)
INTRODUCTION (English)
Copyright © 2024. Published by Elsevier Inc. (English)
2024
The National Surgical Quality Improvement Program databases from 2015 to 2021 were used to identify TGD patients who underwent breast reduction (Current Procedural Terminology code: 19318) and cisgender patients who underwent this procedure for cosmesis or cancer prophylaxis. (English)
METHODS (English)
Copyright © 2024. Published by Elsevier Inc. (English)
2024
Analysis of variance tests, chi-squared tests, unpaired t-tests, and regression models compared complications among cisgender, transgender, and nonbinary patients. (English)
METHODS (English)
Copyright © 2024. Published by Elsevier Inc. (English)
2024
A total of 1222 patients met the inclusion criteria: 380 (31.1%) were cisgender, 769 (62.9%) were transgender, and 73 (6.0%) were nonbinary. (English)
RESULTS (English)
Copyright © 2024. Published by Elsevier Inc. (English)
2024
The proportion of TGD patients grew significantly relative to cisgender patients over the study period (P < 0.001). (English)
RESULTS (English)
Copyright © 2024. Published by Elsevier Inc. (English)
2024
The overall all-cause complication rate was 3.4%, with 4.2% of cisgender, 1.4% of nonbinary, and 3.1% of transgender patients experiencing surgical complications. (English)
RESULTS (English)
Copyright © 2024. Published by Elsevier Inc. (English)
2024
After adjusting for confounding variables, no statistically significant difference was observed in all-cause complication rates between the cohorts. (English)
RESULTS (English)
Copyright © 2024. Published by Elsevier Inc. (English)
2024
In the sample, 19 transgender patients (2.5%) underwent reoperation. (English)
RESULTS (English)
Copyright © 2024. Published by Elsevier Inc. (English)
2024
Transgender patients had a lower likelihood of wound complications (odds ratio: 0.172; 95% confidence interval: 0.035-0.849; P = 0.031) compared to cisgender patients and nonbinary patients. (English)
RESULTS (English)
Copyright © 2024. Published by Elsevier Inc. (English)
2024
None of the patients experienced a severe systemic complication. (English)
RESULTS (English)
Copyright © 2024. Published by Elsevier Inc. (English)
2024
The findings emphasize the growing demand and safety of gender-affirming breast reductions. (English)
CONCLUSIONS (English)
Copyright © 2024. Published by Elsevier Inc. (English)
2024
They underscore the importance of continued research and tailored approaches to delivering care to nonbinary and transgender patients, addressing their diverse needs and improving access to gender-affirming surgeries. (English)
CONCLUSIONS (English)
Copyright © 2024. Published by Elsevier Inc. (English)
2024
Amitai S (English)
Miller (English)
AS
Maria J (English)
Escobar-Domingo (English)
MJ
Bernard T (English)
Lee (English)
BT
Oren (English)
Ganor (English)
O
Samuel J (English)
Lin (English)
SJ
Sophia (English)
Hu (English)
S
Andrea L (English)
Pusic (English)
AL
Manraj N (English)
Kaur (English)
MN
19 October 2024
19 October 2024